IMAC HOLDINGS INC (IMAC)

US44967K1043 - Common Stock

1.01  +0.02 (+2%)

Fundamental Rating

2

IMAC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 118 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of IMAC have multiple concerns. IMAC is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IMAC has reported negative net income.
IMAC had negative earnings in each of the past 5 years.
In the past 5 years IMAC always reported negative operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA -48.41%
ROE N/A
ROIC -45.82%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -72.27%
PM (TTM) -76.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMAC is destroying value.
Compared to 1 year ago, IMAC has more shares outstanding
Compared to 1 year ago, IMAC has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.90, we must say that IMAC is in the distress zone and has some risk of bankruptcy.
IMAC has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.9
ROIC/WACC-5.63
WACC8.14%

2.3 Liquidity

A Current Ratio of 1.27 indicates that IMAC should not have too much problems paying its short term obligations.
IMAC has a Quick Ratio of 1.27. This is a normal value and indicates that IMAC is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27

More info and screens

6

3. Growth

3.1 Past

IMAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.64%, which is quite good.
IMAC shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.05%.
The Revenue has been growing by 272.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q20%
Revenue 1Y (TTM)21.05%
Revenue growth 3Y29.01%
Revenue growth 5Y272.72%
Revenue growth Q2Q27.29%

3.2 Future

The Earnings Per Share is expected to grow by 2.32% on average over the next years.
Based on estimates for the next years, IMAC will show a very strong growth in Revenue. The Revenue will grow by 22.61% on average per year.
EPS Next Y2.98%
EPS Next 2Y7.43%
EPS Next 3Y4.29%
EPS Next 5Y2.32%
Revenue Next Year21.45%
Revenue Next 2Y23.21%
Revenue Next 3Y22.4%
Revenue Next 5Y22.61%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IMAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IMAC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.44

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.43%
EPS Next 3Y4.29%

More info and screens

0

5. Dividend

5.1 Amount

IMAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMAC HOLDINGS INC

NASDAQ:IMAC (8/5/2022, 7:25:24 PM)

1.01

+0.02 (+2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap26.75M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.41%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -72.27%
PM (TTM) -76.98%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y2.98%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.05%
Revenue growth 3Y29.01%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y